# Azafaros

**Canonical:** https://apis.io/providers/azafaros/  
**Website:** https://www.azafaros.com  
**APIs profiled:** 1

Azafaros B.V. develops therapeutic candidates for severe rare metabolic disorders. Its lead program is the orally available azasugar nizubaglustat, designed to treat central nervous system involvement and modulate glycosphingolipid metabolism in lysosomal storage diseases. The company focuses on patients with conditions such as GM1/GM2 gangliosidoses.

## Kin Score — 8.6 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 8.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 10.5 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 10.5 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 15.7 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Azafaros API** — Azafaros does not appear to expose a public API; no documentation or OpenAPI spec was found.

## Security (2)

- **Azafaros Domain Security** — TLSv1.3 · HSTS · DNSSEC · DMARC
- **Azafaros Vulnerability Disclosure** — security.txt · contact published

## Tags

Lysosomal Storage Disorders, Rare Metabolic Disorders

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/azafaros/). Scores are computed from the provider's own public artifacts under a published rubric.